Characteristics of polycystic ovary syndrome with and without insulin resistance and the role of insulin sensitizing drug (metformin) in its management

Middle East Fertility Society Journal

Volumn 10, Issue 2, 2005, Pages 142-149

  Refaie, Ashraf M N ^a   Ibrahim, Gehan A K ^b   Al Oash, Saad ^c  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b ZAGAZIG UNIVERSITY   (Egypt)

^c Zagazig University   (Egypt)

Author keywords

Insulin resistance; Insulin sensitizing drugs; Polycystic ovary

Indexed keywords

CHOLESTEROL; CLOMIFENE CITRATE; FOLLITROPIN; GLUCOSE; INSULIN; LUTEINIZING HORMONE; METFORMIN; PROGESTERONE; TESTOSTERONE; TRIACYLGLYCEROL;

ACANTHOSIS NIGRICANS; ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENDOCRINE FUNCTION; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HIRSUTISM; HUMAN; INFERTILITY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LUTEINIZING HORMONE BLOOD LEVEL; OBESITY; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; PROGESTERONE BLOOD LEVEL; REPRODUCTION; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 26844447757     PISSN: 11105690     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Szilagyi A, Szabo I. Endocrine characteristics of polycystic ovary syndrome (PCOS). Indian J Exp Biol. 2003;41:694-700.
2. Norman RJ, Wu R, Stankiewicz MT. Polycystic ovary syndrome. Med J. 2004;180:132-7
3. Nestler JE, Stovall D, Akhter N, Iuorno MJ, Jakubowiez DJ. Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril 2001;77:209-101
4. Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, type 2 diabetes mellitus. Fertil Steril 2002;77:1095-1105
5. Lergo Rs, Finegood D, Duanif A. Fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998;83:2964-2968
6. Homburg R. Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome Best Pract Res. 2004;18:773-88
7. Ben-Haroush A, Yogev Y, Fisch B. Insulin resistance and metformin in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2004 10;115:125-33.
8. Knochenhaur ES, Yey TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of polycystic ovary syndrome in unselected back and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078-3082
9. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanisms for pathogenesis. Endocr Rev. 1997;18:774-800
10. Mor E, Zograbyan a, Saadat P, Bayrak A, Tourgeman D, Zhang C, et al. The resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis. Am J Obstet Gynecol. 2004;190:1654-1660
11. Dunaif a, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity in polycystic ovary syndrome. Diabetes 1989;38:1163-1174
12. Chang RJ, Nakamura RM, Judd HL, Kaplan SA. Insulin resistance in non obese patients with polycystic ovarian disease. J Clin Edocrinol Metab. 1983;57:356-359
13. Ferrannni E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity. J Clin Invest 1997;100:1166-1173
14. Holte J, Bergh T, Berne C, Berglund L, Lithell H. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab 1994;78:1052-1058
15. Arner P. Control of lipolysis and its relevance to development of obesity in man. Diabetes Metab Rev. 1988;4:507-515
16. Barbieri IL, Ryan KJ. Hyperandrogenism, insulin resistance and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features. Am J Obstet Gynecol 1983;147:90-101
17. Nestler JE, Jakubowicz DJ, Varges AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediator as the signal transduction system. J Clin Endocrinol Metab 1999;83:2001-2005
18. Veldhuis JD, Furlanetta RW. Tropic actions of human somatomedin C-insulin like growth factor I on ovarian cells: In vitro studies with swine granulosa cell. Endocrinology 1985;116:1235-1242
19. Barbieri RL, Smith S, Ryan KJ. The role of hyperisulinaemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril 1988;50:197-212
20. Adashi EY, Hsues AJ, Yen SS. Insulin enhancement of luteinizing hormone and follicle stimulating hormone released by culture pituitary cells. Endocrinology 1981;108:1441-1449
21. Rodriguez N, Arias P, Refojo D, Feledr C, Moguilevsky J. Arrest of pulsatile luteinizing hormone secretion during insulin induced hypoglycemia. Exp Clin endocrinol Diabetes 1999;107:257-261
22. McCarthy EA, Walker SP, McLachlan K, Boyle J, Permezel. Metformin in obstetric and gynecologic practice: a review. Obstet Gynecol Surv 2004;59:118-27. Review
23. Cheang KI, Nestler JE. Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome? Reprod Biomed 2004;8:440-7.
24. Kashyap S, Wells GA, Rosenwaks Z. Insulin-sensitizing agents as primary therapy for patients with polycystic syndrome. Hum Reprod 2004;19:2474-2483
25. Aruna J, Mittal S, Kumar S, Misra R, Dadhwal V, Vimala N. Metformin therapy in women with polycystic ovary syndrome. Int J Gynaecol Obstet. 2004;87:237-41.
26. Liu ZA, Xue YM, Chen LX, Cai Q, Chen H, Zhang J, Cui QH, Ge J, Yuan T. Clinical study on treating insulin resistance and promoting ovulation in polycystic ovary syndrome.] Zhonghua Fu Chan Ke Za Zhi. 2004;39:586-90.
27. Hahn S, Quadbeck B, Elsenbruch S, Gartner R, Finke R, Mann K, Janssen OE. Metformin, an efficacious drug in the treatment of polycystic ovary syndrome. Dtsch Med Wochenschr. 20047;129:1059-64.
28. Baillargeon Jp, Jakubowwicz DJ, Iuorno MJ, Jakubowicz S, Nesler JE. Effects of metformin and rosiglitazone, alone and in combination, in non obese women with polycystic ovary syndrome and normal indices of insulin sensitivity. Fertil Steril. 2004;82:893-902.
29. Palomba S, Orio F Jr, Nardo LG, Falbo A, Russo T, Corea D, Doldo P, Lombardi G, Tolino A, Colao A, Zullo F. Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial. J Clin Endocrinol Metab. 2004;89:4797-800.
30. Sahin Y, Yrimibes U, Kelestimur F, Aygen E. The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2004;113:214-20
31. Kjotrod SB, von During V, Carlsen SM. Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study. Hum Reprod. 2004;19:1315-22.